 "Bonds, Stock markets, Shares, Trading")
Shares of Alembic Pharmaceuticals climbed up to nearly 3 per cent on the BSE in the early trade Thursday, a day after the company said its joint venture firm Aleor Dermaceuticals has completed United States Food and Drug Administration (USFDA) inspection at its formulation manufacturing facility located at Karakhadi, Gujarat without any observations. The inspection was carried out from January 6 to January 8. Click to read press release
Aleor Dermaceuticals is a 60:40 Joint Venture (JV) between Alembic Pharmaceuticals and Orbicular Pharmaceutical Technologies.
At 09:49 am, the stock was trading around 2 per cent higher at
